The effect of valproate on silent period and corticomotor excitability

Epileptic Disorders

Volumn 8, Issue 2, 2006, Pages 136-142

  Kazis, Dimitrios A ^a   Kimiskidis, Vasilios K ^a,d   Papagiannopoulos, Sotirios ^a   Sotirakoglou, Kyriaki ^b   Divanoglou, Daniel ^a   Vlaikidis, Nikolaos ^a   Mills, Kerry R ^c   Kazis, Aristeidis ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b AGRICULTURAL UNIVERSITY OF ATHENS   (Greece)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

^d G Papanikolaou Hospital   (Greece)

Author keywords

Corticomotor threshold; Silent period; Transcranial magnetic stimulation; Valproate

Indexed keywords

VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EVOKED MUSCLE RESPONSE; FEMALE; GENERALIZED EPILEPSY; HUMAN; IDIOPATHIC DISEASE; NERVE EXCITABILITY; PRIORITY JOURNAL; STIMULUS RESPONSE; TRANSCRANIAL MAGNETIC STIMULATION;

ADOLESCENT; ADULT; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY, GENERALIZED; EVOKED POTENTIALS, MOTOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MOTOR CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; VALPROIC ACID;

EID: 33745758760     PISSN: 12949361     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Boroojerdi B, Battaglia F, Muellbacher W, et al. Mechanisms influencing stimulus-response properties of the human corticospinal system. Clin Neurophysiol 2001; 112: 931-7.
2. Bourgeois B, Beaumanoir A, Blajev B, et al. Monotherapy with valproate in primary generalized epilepsies. Epilepsia 1987; 28(Suppl 2): S8-S11.
3. Chen R, Samii A, Canos M, et al. Effects of phenytoin on cortical excitability in humans. Neurology 1997; 49: 881-3.
4. + dependent inhibitory post-synaptic potentials evoked by interneurones of the rat lateral geniculate nucleus. J Physiol 1988; 399: 153-76.
5. Cunningham MO, Woodhall GL, Jones RS. Valproate modifies spontaneous excitation and inhibition at cortical synapses in vitro. Neuropharmacology 2003; 45: 907-17.
6. Delvaux V, Alagona G, Gerard P, et al. Reduced excitability of the motor cortex in untreated patients with de novo idiopathic «grand mal» seizures. J Neurol Neurosurg Psychiatry 2001; 71: 772-6.
7. Engel Jr. J, International League Against Epilepsy (ILAE). A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001; 42: 796-803.
8. Ertas NK, Gul G, Altunhalka A, et al. Cortical silent period following transcranial magnetic stimulation in epileptic patients. Epileptic Disord 2000; 2: 137-40.
9. Inghilleri M, Berardelli A, Marchetti P, et al. Effects of diazepam, baclofen and thiopental on the silent period evoked by transcranial magnetic stimulation in humans. Exp Brain Res 1996; 109: 467-72.
10. Kimiskidis VK, Papagiannopoulos S, Sotirakoglou K, et al. Silent period to transcranial magnetic stimulation: construction and properties of stimulus-response curves in healthy volunteers. Exp Brain Res 2005; 163: 21-31.
11. Kimiskidis VK, Papagiannopoulos S, Sotirakoglou K, et al. The repeatability of corticomotor threshold measurements. Neurophysiol Clin 2004; 34: 259-66.
12. Lee HW, Seo HJ, Cohen LG, et al. Cortical excitability during prolonged antiepileptic drug treatment and drug withdrawal. Clin Neurophysiol 2005; 116: 1105-12.
13. Lockard JS, Levy RH. Valproic acid: reversibly acting drug? Epilepsia 1976; 17: 477-9.
14. B-mediated IPSPs in hippocampal pyramidal cells. J Neurophysiol 1999; 82: 1218-23.
15. Löscher W. Valproic acid: Mechanisms of action. In: Levy RH, Mattson RH, Meldrum BS, Perucca E, eds. Antiepileptic Drugs. Philadelphia: Lippincott Williams & Wilkins, 2002: 767-79.
16. McLean MJ, Mcdonald RL. Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in culture. J Pharmacol Exp Ther 1986; 237: 1001-11.
17. Mills KR, Nithi KA. Corticomotor threshold to magnetic stimulation: normal values and repeatability. Muscle Nerve 1997; 20: 570-6.
18. Mills KR, Boniface SJ, Schubert M. Magnetic brain stimulation with a double coil: the importance of coil orientation. Electroencephalogr Clin Neurophysiol 1992; 85: 17-21.
19. Motulsky H, Christopoulos A. How does a treatment change the curve? In: Motulsky H, Christopoulos A, eds. Fitting models to biological data using linear and non-linear regression. A practical guide to curve fitting. Oxford, New York: Oxford University Press, 2003: 160-87.
20. Nezu A, Kimura S, Ohtsuki N, et al. Transcranial magnetic stimulation in benign childhood epilepsy with centro-temporal spikes. Brain Dev 1997; 19: 134-7.
21. Reutens DC, Berkovic SF, Macdonell RA, et al. Magnetic stimulation of the brain in generalized epilepsy: reversal of cortical hyperexcitability by anticonvulsants. Ann Neurol 1993; 34: 351-5.
22. Rigo JM, Hans G, Nguyen L, et al. The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents. Br J Pharmacol 2002; 136: 659-72.
23. Rowan AJ, Binnie CD, de Beer-Pawlikowski NK, et al. Sodium valproate: serial monitoring of EEG and serum levels. Neurology 1979; 29: 1450-9.
24. Thomson AM, Destexhe A. Dual intracellular recordings and computational models of slow inhibitory postsynaptic potentials in rat neocortical and hippocampal slices. Neuroscience 1999; 92: 1193-215.
25. Ziemann U. Evaluation of epilepsy and anticonvulsants. In: Hallet M, Chokrovrerty S, eds. Magnetic Stimulation in Clinical Neurophysiology. Philadelphia: Elsevier, 2005: 253-65.
26. Ziemann U, Lonnecker S, Steinhoff BJ, et al. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol 1996; 40: 367-78.
27. Ziemann U, Steinhoff BJ, Tergau F, et al. Transcranial magnetic stimulation: its current role in epilepsy research. Epilepsy Res 1998; 30: 11-30.